Renate Pichler
Papers
2
Total Citations
13
H-Index
2
About
Renate Pichler is a leading urologic oncology researcher whose work centers on muscle-invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) response, and surgical outcomes. Her most impactful contribution identified that amplification of 7p12 is significantly associated with pathologic nonresponse to NAC in MIBC—a critical finding given that only 30–40% of patients achieve pathologic downstaging, the strongest predictor of survival. This work, cited 8 times, addresses the urgent need for predictive biomarkers to guide treatment decisions. Pichler also leads large-scale, international collaborative studies on urinary diversion after radical cystectomy, analyzing temporal trends across 6,469 patients from 23 tertiary centers. Her 2025 study, with 5 citations, provides essential data on how clinical determinants and surgical practices have evolved over two decades, directly informing patient counseling and surgical planning. Through these contributions, Pichler bridges molecular pathology and clinical practice, advancing personalized therapy and improving outcomes for bladder cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2